Miranda Y.
About Miranda Y.
Miranda Y. serves as the Associate Director of Regenerative Medicine at ElevateBio, where she has played a pivotal role in developing RNA-based blood reprogramming technology. With a strong background in stem cell research and product development, she has held various significant positions in the field, including at BioIVT and Harvard Stem Cell Institute.
Work at ElevateBio
Miranda Y. currently serves as the Associate Director of Regenerative Medicine at ElevateBio, a position she has held since 2021. In this role, she has been instrumental in spearheading the development of innovative RNA-based blood reprogramming technology. Prior to her current position, she worked as a Senior Scientist in Regenerative Medicine at ElevateBio from 2020 to 2021. As the first hire for the Regenerative Medicine team, she played a key role in establishing the lab space and building the team from the ground up in 2020. Additionally, she contributed to due diligence efforts for strategic partnerships within the organization.
Education and Expertise
Miranda Y. earned her PhD from the University of Rochester School of Medicine and Dentistry. Her academic background laid the foundation for her expertise in regenerative medicine and cell reprogramming. She has demonstrated strong storytelling skills, effectively translating complex project strategies into impactful presentations for both C-Suite and R&D audiences. Her educational qualifications and professional experiences have equipped her with the knowledge necessary to lead initiatives in the field of regenerative medicine.
Background
Miranda Y. has a diverse professional background in regenerative medicine and cell biology. She began her career as a Scientist in R&D and Reprogramming Services at Stemgent from 2012 to 2013. She then advanced to ESI BIO, where she held multiple roles, including Senior Scientist and Director of Cell Reprogramming from 2013 to 2016. Following her tenure at ESI BIO, she worked as a Senior Scientist in Product Development at BioIVT from 2016 to 2019. Additionally, she completed a post-doctoral fellowship at the Harvard Stem Cell Institute from 2007 to 2012, where she played a significant role in establishing clinical grade induced pluripotent stem cells (iPSCs) manufacturing processes.
Achievements
Throughout her career, Miranda Y. has made significant contributions to the field of regenerative medicine. She played a key role in establishing clinical grade induced pluripotent stem cells (iPSCs) manufacturing processes, which are critical for advancing cell therapy applications. At ElevateBio, she has been involved in the development of innovative technologies and has contributed to strategic partnerships. Her ability to communicate complex scientific concepts effectively has allowed her to engage with diverse audiences, including executive leadership and research teams.